Jun 2019
Researchers from the Queensland University of Technology conducted a review of 26 international studies and found that healthcare professionals require more information about medicinal cannabis before they start prescribing it to patients. Read the article here.
ANTG appoints new Business Operations Manager Australian Natural Therapeutics […]
ANTG’s Eve Cannabis product reveals its potential to kill or inhibit cancer cells without impacting normal cells…
ANTG has listed two new THC-dominant medicinal cannabis strains on the Australian Register of Therapeutic Goods (ARTG).
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.
LEARN ABOUT ANTG HERE >